Related Experiment Video
Updated: Jul 31, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Coronavirus Disease 2019, Diabetes, and Inflammation: A Systemic Review
Monique Ferguson1,2, Jaysonn Vel1, Vincent Phan1
1John Sealy School of Medicine, University of Texas Medical Branch, Galveston, Texas, USA.
Insights
People with cardiometabolic diseases like type 2 diabetes and obesity face higher risks from COVID-19 infection, experiencing severe illness and poorer outcomes due to hyperinflammation. Managing inflammation and blood sugar is key for better clinical results.
Area of Science:
- Immunology
- Endocrinology
- Infectious Diseases
Background:
- Cardiometabolic diseases, including type 2 diabetes (T2D) and obesity, are linked to increased susceptibility and severity of coronavirus disease 2019 (COVID-19).
- Hyperinflammation is a proposed shared pathway contributing to poor outcomes in both cardiometabolic diseases and COVID-19.
Purpose of the Study:
- To investigate the role of shared inflammatory biomarkers between COVID-19 and cardiometabolic diseases.
- To evaluate the impact of cardiometabolic conditions on COVID-19 prognosis.
Main Methods:
- Systematic review and evaluation of published data from PubMed, SCOPUS, and WHO COVID-19 databases.
- Inclusion of English articles published from December 2019 to February 2022, with 50 articles selected from 248 identified.
Main Results:
- Individuals with diabetes or obesity exhibit an increased risk of COVID-19 infection, hospitalization, and mortality.
- Diabetic patients face a higher risk of intensive care unit admission.
- COVID-19 infection can increase the risk of developing T2D, particularly in patients with comorbidities, due to heightened inflammatory responses (hyperinflammation).
Conclusions:
- Hyperinflammation exacerbates COVID-19 prognosis in patients with cardiometabolic diseases.
- Controlling blood glucose and ameliorating inflammatory responses are crucial for improving clinical outcomes.
- Clinical evaluation of hyperinflammatory states is critical for managing COVID-19 patients with cardiometabolic conditions.
Abstract:
People with cardiometabolic diseases [namely type 2 diabetes (T2D), obesity, or metabolic syndrome] are more susceptible to coronavirus disease 2019 (COVID-19) infection and endure more severe illness and poorer outcomes. Hyperinflammation has been suggested as a common pathway for both diseases. To examine the role of inflammatory biomarkers shared between COVID-19 and cardiometabolic diseases, we reviewed and evaluated published data using PubMed, SCOPUS, and World Health Organization COVID-19 databases for English articles from December 2019 to February 2022. Of 248 identified articles, 50 were selected and included. We found that people with diabetes or obesity have (i) increased risk of COVID-19 infection; (ii) increased risk of hospitalization (those with diabetes have a higher risk of intensive care unit admissions) and death; and (iii) heightened inflammatory and stress responses (hyperinflammation) to COVID-19, which worsen their prognosis. In addition, COVID-19-infected patients have a higher risk of developing T2D, especially if they have other comorbidities. Treatments controlling blood glucose levels and or ameliorating the inflammatory response may be valuable for improving clinical outcomes in these patient populations. In conclusion, it is critical for health care providers to clinically evaluate hyperinflammatory states to drive clinical decisions for COVID-19 patients.
More Related Videos
Related Concept Videos
Psychoneuroimmunology: Diabetes and Cancer
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Coronary Artery Disease I: Introduction
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

